Radiopharm Theranostics Ltd (RADX) stock
RADXNasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as RDPTF
$0.76−0.03 (-3.80%)
Close on Nov 13, 2026Market cap $8.98MP/E –Yield –
Radiopharm Theranostics cash
Cash and short-term investments held at the end of each period.
Radiopharm Theranostics's cash was $4.14M at Jun 30, 2026. For fiscal 2026 it was $4.14M, down 85.8% from the year before. The highest annual figure on record is $29.12M in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $4.14M | -85.8% |
| FY2025 | Jun 30, 2025 | $29.12M | +56.8% |
| FY2024 | Jun 30, 2024 | $18.58M | +58.8% |
| FY2023 | Jun 30, 2023 | $11.70M | -56.6% |
| FY2022 | Jun 30, 2022 | $26.98M | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $4.14M | -84.7% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $29.12M | – |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $18.58M | – |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $11.70M | – |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $26.98M | – |
See a number that looks wrong?